These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3656120

  • 1. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH, Sullivan MJ, Wright JW, Harding JW.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [Abstract] [Full Text] [Related]

  • 2. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.
    Brain Res; 1990 Apr 23; 514(1):5-10. PubMed ID: 2357530
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ, Harding JW, Wright JW.
    Brain Res; 1988 Jul 26; 456(2):249-53. PubMed ID: 3208081
    [Abstract] [Full Text] [Related]

  • 4. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW, Quirk WS, Hanesworth JM, Harding JW.
    Brain Res; 1988 Feb 16; 441(1-2):215-20. PubMed ID: 3359232
    [Abstract] [Full Text] [Related]

  • 5. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins.
    Ahmad S, Ward PE.
    J Pharmacol Exp Ther; 1990 Feb 16; 252(2):643-50. PubMed ID: 1968973
    [Abstract] [Full Text] [Related]

  • 6. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW, Felix D.
    Brain Res; 1987 Oct 27; 424(2):299-304. PubMed ID: 3676828
    [Abstract] [Full Text] [Related]

  • 7. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
    Dewey AL, Wright JW, Hanesworth JM, Harding JW.
    Brain Res; 1988 May 17; 448(2):369-72. PubMed ID: 3378160
    [Abstract] [Full Text] [Related]

  • 8. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
    Fujimoto M, Mihara S, Shigeri Y, Itazaki K.
    Eur J Pharmacol; 1992 May 14; 215(2-3):259-64. PubMed ID: 1396989
    [Abstract] [Full Text] [Related]

  • 9. Effects of low molecular weight peptides and divalent cations on degradation and binding of angiotensin II.
    Nomura S, Mizutani S, Kurauchi O, Kasugai M, Narita O, Tomoda Y.
    Horm Metab Res; 1990 Aug 14; 22(8):444-8. PubMed ID: 2227802
    [Abstract] [Full Text] [Related]

  • 10. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM, Klein EW, Harding JW, Wright JW.
    Brain Res Bull; 1988 Nov 14; 21(5):731-5. PubMed ID: 3219604
    [Abstract] [Full Text] [Related]

  • 11. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2001 Apr 14; 15(2):143-50. PubMed ID: 11468024
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain.
    Abhold RH, Harding JW.
    J Pharmacol Exp Ther; 1988 Apr 14; 245(1):171-7. PubMed ID: 3283320
    [Abstract] [Full Text] [Related]

  • 13. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS, Harding JW, Wright JW.
    Brain Res Bull; 1987 Jul 14; 19(1):145-7. PubMed ID: 3651838
    [Abstract] [Full Text] [Related]

  • 14. Manipulation of aminopeptidase activities: differential effects on iontophoretically applied angiotensins in rat brain.
    Felix D, Harding JW.
    J Hypertens Suppl; 1986 Dec 14; 4(6):S398-401. PubMed ID: 3475424
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG, Gessner G, Horner E.
    J Pharmacol Exp Ther; 1991 Feb 14; 256(2):614-20. PubMed ID: 1993998
    [Abstract] [Full Text] [Related]

  • 16. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
    Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW.
    J Hypertens Suppl; 1986 Dec 14; 4(6):S408-11. PubMed ID: 3475426
    [Abstract] [Full Text] [Related]

  • 17. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q, Zhang J, Pfaffendorf M, van Zwieten PA.
    Br J Pharmacol; 1996 Aug 14; 118(7):1653-8. PubMed ID: 8842428
    [Abstract] [Full Text] [Related]

  • 18. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
    Jensen LL, Harding JW, Wright JW.
    Brain Res; 1989 Jun 19; 490(1):48-55. PubMed ID: 2758329
    [Abstract] [Full Text] [Related]

  • 19. Effect of bestatin on angiotensin I-, II- and III-induced collagen gel contraction in cardiac fibroblasts.
    Lijnen P, Petrov V, Diaz-Araya G, Fagard R.
    J Renin Angiotensin Aldosterone Syst; 2004 Dec 19; 5(4):183-8. PubMed ID: 15803436
    [Abstract] [Full Text] [Related]

  • 20. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ, Cunoosamy MP, Clark KL.
    Br J Pharmacol; 1992 May 19; 106(1):166-72. PubMed ID: 1354540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.